Biocardiaincis A Clinical Stage Regenerative Medicine Company Based In Sunnyvalecaliforniafounded In 2016It Focuses On Developing Cellular And Cell Derived Therapeutics For Cardiovascular And Pulmonary Diseasesthe Company Is Led By Ceo Peter Altmanphdand Co Founded By Interventional Cardiology Pioneer Drsimon Stertzerbiocardia Aims To Address Unmet Medical Needs In Heart And Lung Conditions The Companyae S Key Products Include The Cardiamp Cell Therapy Systemwhich Is In Phase Iii Trials For Ischemic Heart Failure And Refractory Anginaand An Allogeneic Cell Therapy Platform Currently In Phase I Ii Trials For Ischemic Heart Failure And Acute Respiratory Distress Syndromeards Biocardia Also Offers The Helix Biotherapeutic Delivery System For Targeted Biologic Delivery To The Heart And Morph Deflectable Guides And Sheaths For Precise Navigation During Cardiac Proceduresthe Company Collaborates With Partners Like Cellprothera To Advance Its Clinical Trials And Therapeutic Validation
